RecruitingNCT04330521
Impact of the Coronavirus (COVID-19) on Patients With Cancer
Sponsor
Stanford University
Enrollment
50 participants
Start Date
Apr 8, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to understand the impact of COVID-19 on patients with cancer through a survey.
Eligibility
Min Age: 18 YearsMax Age: 99 Years
Plain Language Summary
Simplified for easier understanding
This study is a survey-based research project exploring how the COVID-19 pandemic has affected people who have cancer — including disruptions to their treatment, emotional wellbeing, and access to healthcare. Researchers want to understand the broader impact of the pandemic on this vulnerable group.
**You may be eligible if...**
- You are 18 years or older
- You have a cancer diagnosis
- You are willing and able to participate in a verbal interview or survey
**You may NOT be eligible if...**
- You are under 18 years old
- You are unable or unwilling to verbally consent to the interview
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04330521
Related Trials
A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes
NCT072211628 locations
Patient-Centered Assessment of Symptoms and Outcomes
NCT039526241 location
A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
NCT055881411 location
Tumor Related Epilepsy
NCT026393251 location
Improving Engagement in HIV and Cancer Care in Zimbabwe
NCT069343691 location